Literature DB >> 23681571

Determination of ADP-ribosyl cyclase activity, cyclic ADP-ribose, and nicotinic acid adenine dinucleotide phosphate in tissue extracts.

Richard M Graeff1, Hon Cheung Lee.   

Abstract

Cyclic ADP-ribose (cADPR) is a novel second messenger that releases calcium from intracellular stores. Although first shown to release calcium in the sea urchin egg, cADPR has been shown since to be active in a variety of cells and tissues, from plant to human. cADPR stimulates calcium release via ryanodine receptors although the mechanism is still not completely understood. cADPR is produced enzymatically from NAD by ADP-ribosyl cyclases; several of these proteins have been identified including one isolated from Aplysia californica, two types found in mammals (CD38 and CD157), and three forms in sea urchin. A cyclase activity has been measured in extracts from Arabidopsis thaliana although the protein is still unidentified. Nicotinic acid adenine dinucleotide phosphate (NAADP) is another novel messenger that releases calcium from internal stores and is produced by these same enzymes by an exchange reaction. NAADP targets lysosomal stores whereas cADPR releases calcium from the endoplasmic reticulum. Due to their importance in cell signaling, cADPR and NAADP have been the focus of numerous investigations over the last 25 years. This chapter describes several assay methods for the measurements of cADPR and NAADP concentration and cyclase activity in extracts from cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681571     DOI: 10.1007/978-1-62703-441-8_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion.

Authors:  James Boslett; Craig Hemann; Fedias L Christofi; Jay L Zweier
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-29       Impact factor: 4.249

2.  Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury.

Authors:  James Boslett; Nikhil Reddy; Yasmin A Alzarie; Jay L Zweier
Journal:  J Pharmacol Exp Ther       Date:  2019-01-11       Impact factor: 4.030

3.  Airway responsiveness in CD38-deficient mice in allergic airway disease: studies with bone marrow chimeras.

Authors:  Alonso G P Guedes; Joseph A Jude; Jaime Paulin; Laura Rivero-Nava; Hirohito Kita; Frances E Lund; Mathur S Kannan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-09       Impact factor: 5.464

4.  CD157 in bone marrow mesenchymal stem cells mediates mitochondrial production and transfer to improve neuronal apoptosis and functional recovery after spinal cord injury.

Authors:  Jing Li; Heyangzi Li; Simin Cai; Shi Bai; Huabo Cai; Xiaoming Zhang
Journal:  Stem Cell Res Ther       Date:  2021-05-17       Impact factor: 6.832

5.  Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease.

Authors:  Olga Lopatina; Toru Yoshihara; Tomoko Nishimura; Jing Zhong; Shirin Akther; Azam A K M Fakhrul; Mingkun Liang; Chiharu Higashida; Kohei Sumi; Kazumi Furuhara; Yuki Inahata; Jian-Jung Huang; Keita Koizumi; Shigeru Yokoyama; Takahiro Tsuji; Yulia Petugina; Andrei Sumarokov; Alla B Salmina; Koji Hashida; Yasuko Kitao; Osamu Hori; Masahide Asano; Yoji Kitamura; Takashi Kozaka; Kazuhiro Shiba; Fangfang Zhong; Min-Jue Xie; Makoto Sato; Katsuhiko Ishihara; Haruhiro Higashida
Journal:  Front Behav Neurosci       Date:  2014-04-22       Impact factor: 3.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.